Skip to main content
Premium Trial:

Request an Annual Quote

Entigen Hires Former Incyte VP as New CEO

NEW YORK, June 28 - Entigen has hired Denise Gilbert, a former executive at Incyte and Affymax, as the company's new CEO, Entigen announced Thursday.

As CEO, Gilbert will work on marketing Entigen's technology platform and expanding the business beyond its traditional focus on bioinformatics. The company has yet to disclose specifics on its new direction.

Gilbert joins Entigen after serving as executive vice president and chief financial officer at Incyte. Prior to that, she served as vice president and chief financial officer at Affymax, (the company that spawned Affymetrix) where she participated in the company's 1995 acquisition by Glaxo Wellcome.

Prior to her six years as an executive in genomics companies, Gilbert, a PhD-trained biologist, spent seven years as a biotechnology analyst on Wall Street.

"Denise understands the technical challenges researchers must overcome to make productive use of abundant but geographically dispersed, heterogeneous life science data, can articulate the role of Entigen as a commercial solutions provider, and has the internal and external corporate management experience needed to execute our corporate strategy," Entigen chairman Bala Manian said in a statement.

Entigen, based in Sunnyvale, Calif., was formed in December 2000 from the merger of eBioinformatics, a provider of online software tools for life science data analysis, and Empatheon, which developed ADAAPT (Advanced Dynamic Access, Analysis, and Personalization Technology), a Java-based technology for accessing multiple types of biological data. 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.